---
title: "Viracta Therapeutics (VIRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VIRX.US/norm.md"
symbol: "VIRX.US"
name: "Viracta Therapeutics"
parent: "https://longbridge.com/en/quote/VIRX.US.md"
datetime: "2026-05-20T23:47:43.877Z"
locales:
  - [en](https://longbridge.com/en/quote/VIRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VIRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VIRX.US/norm.md)
---

# Viracta Therapeutics (VIRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2667 | -0.2495 | -0.2325 | -0.3549 | -0.3257 |
| ROE | 898.32% | -2762.21% | -395.39% | -294.26% | -168.32% |
| Revenue | - | - | - | - | - |
| Net income | -10.55M | -9.83M | -9.14M | -13.77M | -12.60M |

## Balance Sheet (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 21.96M | 31.32M | 41.33M | 56.69M | 66.44M |
| Leverage | -3.32 | 11.73 | 3.73 | 3.09 | 2.21 |
| BVPS | -0.1665 | -0.0706 | 0.1433 | 0.3291 | 0.6358 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -7.09M | -9.83M | -7.85M | -10.03M | -10.54M |
| Investing CF | 8.16M | 11.70M | 14.19M | 9.27M | 9.10M |
| Financing CF | -1.92M | 43000.00 | -6.60M | 218000.00 | 0.0000 |
| Free CF | -2.78M | -5.77M | -8.39M | -4.43M | -5.31M |